HEADER HYDROLASE/HYDROLASE INHIBITOR 24-JAN-08 3C27 TITLE CYANOFLUOROPHENYLACETAMIDES AS ORALLY EFFICACIOUS THROMBIN INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 334-359; COMPND 5 EC: 3.4.21.5; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: UNP RESIDUES 364-622; COMPND 10 EC: 3.4.21.5; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: HIRUDIN-3A; COMPND 14 CHAIN: H; COMPND 15 FRAGMENT: UNP RESIDUES 55-65; COMPND 16 SYNONYM: HIRUDIN IIIA; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 GENE: F2; SOURCE 10 MOL_ID: 3; SOURCE 11 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS; SOURCE 12 ORGANISM_COMMON: MEDICINAL LEECH; SOURCE 13 ORGANISM_TAXID: 6421 KEYWDS THROMBIN, SERINE PROTEASE, ACUTE PHASE, BLOOD COAGULATION, GAMMA- KEYWDS 2 CARBOXYGLUTAMIC ACID, GLYCOPROTEIN, HYDROLASE, KRINGLE, PROTEASE, KEYWDS 3 SECRETED, ZYMOGEN, PROTEASE INHIBITOR, SERINE PROTEASE INHIBITOR, KEYWDS 4 SULFATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.C.SPURLINO,M.MCMILLAN,F.LEWANDOWSKI,C.MILLIGAN REVDAT 2 13-JUL-11 3C27 1 VERSN REVDAT 1 17-FEB-09 3C27 0 JRNL AUTH K.D.KREUTER,L.LEE,T.LU,E.C.GIARDINO,S.PATEL,H.HAUNG,G.XU, JRNL AUTH 2 M.FITZGERALD,M.MOHAN,C.CRYSLER,S.EISENNAGEL,M.DASGUPTA, JRNL AUTH 3 M.MCMILLAN,J.C.SPURLINO,N.HEUBERT,B.E.MARYANOFF,B.E.TOMCZUK, JRNL AUTH 4 B.P.DAMIANO,M.R.PLAYER JRNL TITL CYANOFLUOROPHENYLACETAMIDES AS ORALLY EFFICACIOUS THROMBIN JRNL TITL 2 INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.08 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 18406 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 938 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.0880 - 4.1730 0.51 2580 133 0.1490 0.1780 REMARK 3 2 4.1730 - 3.3120 0.50 2498 132 0.1490 0.1480 REMARK 3 3 3.3120 - 2.8940 0.50 2530 143 0.1980 0.2850 REMARK 3 4 2.8940 - 2.6290 0.51 2535 126 0.1990 0.2360 REMARK 3 5 2.6290 - 2.4410 0.51 2540 127 0.1980 0.2340 REMARK 3 6 2.4410 - 2.2970 0.51 2511 146 0.1920 0.2680 REMARK 3 7 2.2970 - 2.1820 0.45 2274 131 0.1920 0.2730 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 45.63 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.55800 REMARK 3 B22 (A**2) : 2.98800 REMARK 3 B33 (A**2) : -2.43100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.51300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2408 REMARK 3 ANGLE : 1.232 3245 REMARK 3 CHIRALITY : 0.080 332 REMARK 3 PLANARITY : 0.006 419 REMARK 3 DIHEDRAL : 20.355 927 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3C27 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-AUG-08. REMARK 100 THE RCSB ID CODE IS RCSB046248. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : MACSCIENCE REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER SMART 6000 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18406 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.182 REMARK 200 RESOLUTION RANGE LOW (A) : 50.075 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.42700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.01300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.42700 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.01300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR B 182A REMARK 465 TRP B 182B REMARK 465 THR B 182C REMARK 465 ALA B 182D REMARK 465 ASN B 182E REMARK 465 VAL B 182F REMARK 465 GLY B 182G REMARK 465 LYS B 182H REMARK 465 GLY B 288 REMARK 465 GLU B 289 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 106 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 15 -91.70 -128.58 REMARK 500 TYR B 83 83.63 -154.97 REMARK 500 ASN B 89 79.07 -157.84 REMARK 500 HIS B 102 -63.40 -125.48 REMARK 500 ASN B 131 16.54 -142.49 REMARK 500 SER B 256 -80.99 -118.78 REMARK 500 GLU H 297 -56.11 -11.11 REMARK 500 LEU H 299 41.70 -85.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU H 296 GLU H 297 137.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKK B 5000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF HIRUDIN-3A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2R2M RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH INHIBITOR I50 DBREF 3C27 A 7 32 UNP P00734 THRB_HUMAN 334 359 DBREF 3C27 B 37 289 UNP P00734 THRB_HUMAN 364 622 DBREF 3C27 H 290 300 UNP P28507 HIR3A_HIRME 55 65 SEQRES 1 A 26 ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER SEQRES 2 A 26 LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 H 11 ASP PHE GLU GLU ILE PRO GLU GLU TYR LEU GLN HET DKK B5000 31 HETNAM DKK N-[2-(CARBAMIMIDAMIDOOXY)ETHYL]-2-{6-CYANO-3-[(2,2- HETNAM 2 DKK DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-2- HETNAM 3 DKK FLUOROPHENYL}ACETAMIDE FORMUL 4 DKK C19 H20 F3 N7 O2 FORMUL 5 HOH *116(H2 O) HELIX 1 1 PHE A 15 SER A 19 5 5 HELIX 2 2 THR A 24 TYR A 32 1 9 HELIX 3 3 ALA B 77 CYS B 80 5 4 HELIX 4 4 PRO B 84 ASP B 87 5 4 HELIX 5 5 THR B 91 ASN B 93 5 3 HELIX 6 6 ASP B 158 LEU B 166 1 9 HELIX 7 7 GLU B 199 SER B 206 1 8 HELIX 8 8 LEU B 276 PHE B 287 1 12 HELIX 9 9 PRO H 295 LEU H 299 5 5 SHEET 1 A 7 SER B 41 ASP B 42 0 SHEET 2 A 7 GLN B 191 PRO B 196 -1 O VAL B 192 N SER B 41 SHEET 3 A 7 LYS B 171 GLY B 176 -1 N GLY B 172 O LEU B 195 SHEET 4 A 7 PRO B 238 LYS B 242 -1 O VAL B 240 N ARG B 173 SHEET 5 A 7 TRP B 249 TRP B 257 -1 O TYR B 250 N MET B 241 SHEET 6 A 7 GLY B 268 HIS B 272 -1 O PHE B 269 N TRP B 257 SHEET 7 A 7 MET B 215 ALA B 218 -1 N PHE B 216 O TYR B 270 SHEET 1 B 7 GLN B 51 ARG B 56 0 SHEET 2 B 7 GLU B 61 LEU B 68 -1 O LEU B 63 N LEU B 54 SHEET 3 B 7 TRP B 73 THR B 76 -1 O LEU B 75 N SER B 67 SHEET 4 B 7 ALA B 137 LEU B 141 -1 O ALA B 137 N THR B 76 SHEET 5 B 7 LYS B 113 ILE B 122 -1 N GLU B 118 O LYS B 140 SHEET 6 B 7 LEU B 95 ILE B 99 -1 N ILE B 99 O LYS B 113 SHEET 7 B 7 GLN B 51 ARG B 56 -1 N PHE B 55 O LEU B 96 SHEET 1 C 2 LEU B 82 TYR B 83 0 SHEET 2 C 2 LYS B 88 ASN B 89 -1 O LYS B 88 N TYR B 83 SSBOND 1 CYS A 9 CYS B 155 1555 1555 2.02 SSBOND 2 CYS B 64 CYS B 80 1555 1555 2.03 SSBOND 3 CYS B 203 CYS B 217 1555 1555 1.99 SSBOND 4 CYS B 231 CYS B 261 1555 1555 2.03 CISPEP 1 SER B 58 PRO B 59 0 -3.54 SITE 1 AC1 17 HIS B 79 TYR B 83 GLU B 130 ASP B 229 SITE 2 AC1 17 ALA B 230 CYS B 231 SER B 235 VAL B 255 SITE 3 AC1 17 SER B 256 TRP B 257 GLY B 258 GLU B 259 SITE 4 AC1 17 GLY B 260 CYS B 261 HOH B5019 HOH B5039 SITE 5 AC1 17 HOH B5044 SITE 1 AC2 12 PHE B 55 LYS B 57 GLN B 60 LEU B 62 SITE 2 AC2 12 LEU B 96 ARG B 104 THR B 105 ARG B 106 SITE 3 AC2 12 TYR B 107 HOH B5068 HOH H 49 HOH H 73 CRYST1 70.854 72.026 72.987 90.00 100.50 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014114 0.000000 0.002617 0.00000 SCALE2 0.000000 0.013884 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013935 0.00000 MASTER 272 0 1 9 16 0 8 6 0 0 0 23 END